查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1886340

蛋白A樹脂市場－全球產業規模、佔有率、趨勢、機會和預測，按產品、基質類型、應用（免疫沉澱、抗體純化）、最終用戶、地區和競爭格局分類，2020-2030年預測

Protein A Resin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Matrix Type, By Application (Immunoprecipitation, Antibody Purification), By End User, By Region, and By Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 186 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年全球蛋白A樹脂市場規模為13.8億美元，預計2030年將以10.04%的複合年成長率成長至24.5億美元。蛋白A樹脂是一種親和層析介質，主要用於從複雜的生物混合物中純化抗體，特別是免疫球蛋白G，其純化方法是透過與Fc區特異性結合來實現的。市場擴張的根本驅動力是全球對單株抗體療法的需求不斷成長，尤其是在治療慢性疾病方面，以及生物製藥研發投入的增加。

市場概覽
預測期 2026-2030
市場規模：2024年 13.8億美元
市場規模：2030年 24.5億美元
複合年成長率：2025-2030年 10.04%
成長最快的細分市場 天然蛋白質A
最大的市場 北美洲

主要市場促進因素

單株抗體和生物製劑需求的不斷成長顯著推動了Protein A樹脂市場的發展，因為這些治療藥物需要高效的純化方法才能滿足嚴格的品質和監管要求。這些藥物治療應用範圍的擴大和全球範圍內的普及，直接催生了對先進下游加工技術的需求。

主要市場挑戰

蛋白A樹脂固有的高成本嚴重阻礙了全球蛋白A樹脂市場的擴張。這筆巨額支出構成了相當大的推廣門檻，尤其對於預算有限的小型企業和新興生物製藥公司而言更是如此。

主要市場趨勢

高容量、耐鹼樹脂的開發是全球蛋白A樹脂市場的一大趨勢，它能直接提高純化效率，並降低生物製藥企業的營運成本。這些先進樹脂能夠更快地處理更多生物製劑，鑑於抗體療法的需求日益成長，這一點至關重要。

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球蛋白A樹脂市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依產品（天然蛋白A、重組蛋白A）
    • 依基質類型（瓊脂糖基、玻璃或二氧化矽基、有機聚合物基）
    • 依應用（免疫沉澱（IP）、抗體純化）
    • 依最終用戶（生物製藥生產商、臨床研究實驗室、學術機構）分類
    • 按地區
    • 按公司（2024 年）
  • 市場地圖

第6章：北美蛋白A樹脂市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲蛋白A樹脂市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區蛋白A樹脂市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲蛋白A樹脂市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲蛋白A樹脂市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章：市場動態

  • 促進要素
  • 挑戰

第12章：市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章：全球蛋白A樹脂市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章：競爭格局

  • GE Healthcare Inc.
  • Merck Millipore (Merck KGaA)
  • PerkinElmer, Inc.
  • GenScript Biotech Corp.
  • Agilent Technologies, Inc.
  • Repligen Corp.
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories, Inc.
  • Abcam PLC.
  • Novasep Holdings SAS

第16章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 23786

The Global Protein A Resin Market, valued at USD 1.38 Billion in 2024, is projected to experience a CAGR of 10.04% to reach USD 2.45 Billion by 2030. Protein A resin is an affinity chromatography medium primarily used for the purification of antibodies, especially immunoglobulin G, from complex biological mixtures through specific binding to the Fc region. The market's expansion is fundamentally driven by the escalating global demand for monoclonal antibody therapeutics, particularly in treating chronic diseases, and increasing investments in biopharmaceutical research and development.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 1.38 Billion
Market Size 2030USD 2.45 Billion
CAGR 2025-203010.04%
Fastest Growing SegmentNatural Protein A
Largest MarketNorth America

Key Market Drivers

The increasing demand for monoclonal antibodies and biologics significantly drives the Protein A resin market, as these therapeutics require highly efficient purification methods to meet stringent quality and regulatory guidelines. The expanding therapeutic applications and global adoption of these medicines directly necessitate advanced downstream processing.

Key Market Challenges

The inherently high cost associated with Protein A resins significantly impedes the expansion of the Global Protein A Resin Market. This substantial expenditure acts as a considerable adoption barrier, particularly for smaller entities and emerging biopharmaceutical companies operating with constrained budgets. Such financial pressure compels some manufacturers to explore less efficient, yet more affordable, alternative purification strategies. This decision often compromises the overall yield and purity achievable, thereby directly impacting the quality and cost-effectiveness of the final biologic product.

Key Market Trends

The development of high-capacity and alkali-stable resins represents a significant trend in the Global Protein A Resin Market by directly enhancing purification efficiency and reducing operational costs for biopharmaceutical manufacturers. These advanced resins enable the processing of larger quantities of biologics within shorter timeframes, which is crucial given the increasing demand for antibody therapeutics.

Key Market Players

  • GE Healthcare Inc.
  • Merck Millipore (Merck KGaA)
  • PerkinElmer, Inc.
  • GenScript Biotech Corp.
  • Agilent Technologies, Inc.
  • Repligen Corp.
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories, Inc.
  • Abcam PLC.
  • Novasep Holdings SAS

Report Scope:

In this report, the Global Protein A Resin Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Protein A Resin Market, By Product:

  • Natural Protein A
  • Recombinant Protein A

Protein A Resin Market, By Matrix Type:

  • Agarose-based
  • Glass or Silica Based
  • Organic Polymer Based

Protein A Resin Market, By Application:

  • Immunoprecipitation (IP)
  • Antibody Purification

Protein A Resin Market, By End User:

  • Biopharmaceutical Manufacturers
  • Clinical Research Laboratories
  • Academic Institutes

Protein A Resin Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Protein A Resin Market.

Available Customizations:

Global Protein A Resin Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Protein A Resin Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Natural Protein A, Recombinant Protein A)
    • 5.2.2. By Matrix Type (Agarose-based, Glass or Silica Based, Organic Polymer Based)
    • 5.2.3. By Application (Immunoprecipitation (IP), Antibody Purification)
    • 5.2.4. By End User (Biopharmaceutical Manufacturers, Clinical Research Laboratories, Academic Institutes)
    • 5.2.5. By Region
    • 5.2.6. By Company (2024)
  • 5.3. Market Map

6. North America Protein A Resin Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Matrix Type
    • 6.2.3. By Application
    • 6.2.4. By End User
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Protein A Resin Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Matrix Type
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By End User
    • 6.3.2. Canada Protein A Resin Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Matrix Type
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By End User
    • 6.3.3. Mexico Protein A Resin Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Matrix Type
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By End User

7. Europe Protein A Resin Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Matrix Type
    • 7.2.3. By Application
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Protein A Resin Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Matrix Type
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End User
    • 7.3.2. France Protein A Resin Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Matrix Type
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End User
    • 7.3.3. United Kingdom Protein A Resin Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Matrix Type
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End User
    • 7.3.4. Italy Protein A Resin Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Matrix Type
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By End User
    • 7.3.5. Spain Protein A Resin Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Matrix Type
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By End User

8. Asia Pacific Protein A Resin Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Matrix Type
    • 8.2.3. By Application
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Protein A Resin Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Matrix Type
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End User
    • 8.3.2. India Protein A Resin Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Matrix Type
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End User
    • 8.3.3. Japan Protein A Resin Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Matrix Type
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End User
    • 8.3.4. South Korea Protein A Resin Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Matrix Type
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End User
    • 8.3.5. Australia Protein A Resin Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Matrix Type
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End User

9. Middle East & Africa Protein A Resin Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Matrix Type
    • 9.2.3. By Application
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Protein A Resin Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Matrix Type
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End User
    • 9.3.2. UAE Protein A Resin Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Matrix Type
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End User
    • 9.3.3. South Africa Protein A Resin Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Matrix Type
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End User

10. South America Protein A Resin Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Matrix Type
    • 10.2.3. By Application
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Protein A Resin Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Matrix Type
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End User
    • 10.3.2. Colombia Protein A Resin Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Matrix Type
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End User
    • 10.3.3. Argentina Protein A Resin Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Matrix Type
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Protein A Resin Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. GE Healthcare Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Merck Millipore (Merck KGaA)
  • 15.3. PerkinElmer, Inc.
  • 15.4. GenScript Biotech Corp.
  • 15.5. Agilent Technologies, Inc.
  • 15.6. Repligen Corp.
  • 15.7. Thermo Fisher Scientific Inc.
  • 15.8. Bio-Rad Laboratories, Inc.
  • 15.9. Abcam PLC.
  • 15.10. Novasep Holdings SAS

16. Strategic Recommendations

17. About Us & Disclaimer